Navigation Links
Cell Biosciences Acquires Protein Forest
Date:12/7/2009

SANTA CLARA, Calif., Dec. 7 /PRNewswire/ -- Cell Biosciences, Inc. today announced that it has acquired Protein Forest, Inc. of Lexington, Massachusetts, a leader in sample preparation technology for proteomic analysis and biomarker discovery. This strategic acquisition adds Protein Forest's novel digital ProteomeChip(TM) product line to Cell Biosciences' expanding portfolio of innovative products for protein analysis.

Protein Forest, founded in 2002, pioneered a new technology for rapid, highly reproducible protein fractionation of complex biological samples - an important prerequisite step for quantitative proteomics measurements. The technology can be used as a sample preparation front-end for many protein analysis techniques, including western blot analysis, mass spectrometry, and the Cell Biosciences' nanoproteomic platforms. The digital ProteomeChip product line includes instrumentation, software, reagents, and proprietary consumables.

Cell Biosciences is a private life sciences company focused on defining the future of protein analysis. The company's products include novel nanofluidic assay systems for ultrasensitive protein analysis, and a complete line of leading digital imaging systems for proteomic and genomic research. Cell Biosciences has approximately 100 employees in North America, Europe and Asia, and its products are sold in more than 40 countries.

Commenting on the transaction, Tim Harkness, President and Chief Executive Officer of Cell Biosciences, said, "This acquisition adds an exciting sample preparation product line to our growing protein analysis business. The lack of reproducible sample preparation has become a serious problem for proteomics researchers. We believe that the digital ProteomeChip products represent a powerful solution for this market need. The digital ProteomeChip product line fits perfectly with our strategic plan and will be leveraged immediately by our global distribution organization."

In connection with the all-stock acquisition, Cell Biosciences raised an additional $4 million in an equity financing, led by Novo A/S.

ABOUT CELL BIOSCIENCES

Cell Biosciences is a private life sciences company focused on defining the future of protein analysis. The Company develops instrumentation systems, sample preparation systems, software and assay products that drive discoveries in fields ranging from fundamental protein research to biomarker discovery and personalized medicine. With an installed base of over 10,000 systems, its customers include leading research institutions, pharmaceutical and biotechnology companies worldwide. Cell Biosciences is headquartered in Santa Clara, California. For more information, visit www.cellbiosciences.com.

SOURCE Cell Biosciences, Inc.


'/>"/>
SOURCE Cell Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc.
2. Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops
3. Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference
4. YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA
5. American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor
6. Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS
7. YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING
8. Regado Biosciences to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17, 2009
9. YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS
10. Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 16, 2009
11. Sangamo BioSciences Announces Presentation at Merriman Curhan Fords Investor Summit 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Jan. 17, 2017  Northwell Health today announced ... of precision cancer research. As ... health care provider, Northwell Health diagnoses and treats ... is a Germany -based oncology ... Together they will greatly expand cancer biobanking activities ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... epigenetics research, recently announced a collaboration with the Heidelberg University Hospital and the ... for library preparation, following the company’s successful launch of its CATS (Capture ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... Tibbetts Award from the U.S. Small Business Administration. The Tibbetts Award honors ... or social impact […] and are considered the best of the best from ...
(Date:1/13/2017)... , Jan 13, 2017 Research and Markets ... report to their offering. ... The global biopolymers market to grow at a CAGR of 16.83% during ... and the growth prospects of the global biopolymers market for 2017-2021. To ... sale of sales of biopolymer products. The report also includes a a ...
Breaking Biology Technology:
(Date:1/12/2017)... , Jan. 12, 2017  New research undertaken by ... of the future.  1,000 participants were simply asked which office ... which we may consider standard issue.  Insights on what ... were also gathered from futurists and industry leaders including ... James Canton .  Some of these ...
(Date:1/11/2017)... 11, 2017  Michael Johnson, co-founder of Visikol Inc. a company ... has been named to the elite "Forbes 30 Under 30" list ... 600 people in 20 fields nationwide to be recognized as a ... applicants were selected. ... He is currently a PhD candidate at Rutgers University. ...
(Date:1/6/2017)... 5, 2017  Delta ID Inc., a leader in ... for automotive at CES® 2017. Delta ID has collaborated ... demonstrate the use of iris scanning as a secure, ... driver in a car, and as a way to ... Delta ID and Gentex will demonstrate (booth ...
Breaking Biology News(10 mins):